Cargando…

Conformation-Specific Inhibitory Anti-MMP-7 Monoclonal Antibody Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Chemotherapeutic Cell Kill

SIMPLE SUMMARY: Extracellular matrix remodeling enzymes are dysregulated in several pathologies. Our aim was to generate a unique function blocking monoclonal antibody against one such cancer-associated enzyme, matrix metalloproteinase 7 (MMP-7). We generated GSM-192, with high affinity and specific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohan, Vishnu, Gaffney, Jean P., Solomonov, Inna, Levin, Maxim, Klepfish, Mordehay, Akbareian, Sophia, Grünwald, Barbara, Dym, Orly, Eisenstein, Miriam, Yu, Kenneth H., Kelsen, David P., Krüger, Achim, Edwards, Dylan R., Sagi, Irit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038143/ https://www.ncbi.nlm.nih.gov/pubmed/33918254 http://dx.doi.org/10.3390/cancers13071679

Ejemplares similares

LOXL2 Inhibition Paves the Way for Macrophage-Mediated Collagen Degradation in Liver Fibrosis
por: Klepfish, Mordehay, et al.
Publicado: (2020)

Cardiac remodeling secondary to chronic volume overload is attenuated by a novel MMP9/2 blocking antibody
por: Cohen, Lena, et al.
Publicado: (2020)

Correction: Cardiac remodeling secondary to chronic volume overload is attenuated by a novel MMP9/2 blocking antibody
por: Cohen, Lena, et al.
Publicado: (2020)

Tumor macrophages are pivotal constructors of tumor collagenous matrix
por: Afik, Ran, et al.
Publicado: (2016)

Introduction of correlative light and airSEM(TM) microscopy imaging for tissue research under ambient conditions
por: Solomonov, Inna, et al.
Publicado: (2014)

MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy
por: Owyong, Mark, et al.
Publicado: (2019)

Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in Ductal Carcinoma in Situ and Invasive Ductal Carcinoma of the Breast
por: Kim, Hee Jung, et al.
Publicado: (2006)

Concerted cell and in vivo screen for pancreatic ductal adenocarcinoma (PDA) chemotherapeutics
por: Layeghi-Ghalehsoukhteh, Somayeh, et al.
Publicado: (2020)

MMP-9 Responsive PEG Cleavable Nanovesicles for Efficient Delivery of Chemotherapeutics to Pancreatic Cancer
por: Kulkarni, Prajakta S., et al.
Publicado: (2014)

Chemotherapeutical treatment of basal cell carcinoma with bleomycin via microinfusion of the drug into the skin (MMP®)()
por: Pacola, Paulo Rodrigo, et al.
Publicado: (2023)

Multidrug resistance genes screening of pancreatic ductal adenocarcinoma based on sensitivity profile to chemotherapeutic drugs
por: Zhao, Bangbo, et al.
Publicado: (2022)

High-concentration glucose enhances invasion in invasive ductal breast carcinoma by promoting Glut1/MMP2/MMP9 axis expression
por: Sun, Xian-Fu, et al.
Publicado: (2017)

Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells
por: Thijssen, Rachel, et al.
Publicado: (2020)

Orthodox Judaism as a Risk Factor of Covid-19 in Israel
por: Schattner, Ami, et al.
Publicado: (2020)

Evening Primrose Oil Improves Chemotherapeutic Effects in Human Pancreatic Ductal Adenocarcinoma Cell Lines—A Preclinical Study
por: Zeppa, Laura, et al.
Publicado: (2022)

De Novo Evolutionary Emergence of a Symmetrical Protein Is Shaped by Folding Constraints
por: Smock, Robert G., et al.
Publicado: (2016)

Phylogeny and biogeography of the algal DMS-releasing enzyme in the global ocean
por: Shemi, Adva, et al.
Publicado: (2023)

CHEMOTHERAPEUTIC EQUILIBRIA
por: Stearn, Allen E., et al.
Publicado: (1930)

Chemotherapeutic Antiseptics
por: Browning, C. H.
Publicado: (1937)

Detection of serum VEGF and MMP-9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinoma
por: ZHANG, JUNYING, et al.
Publicado: (2014)

Cytokine secretion and NK cell activity in human ADAM17 deficiency
por: Tsukerman, Pinchas, et al.
Publicado: (2015)

ATG4B Inhibitor UAMC-2526 Potentiates the Chemotherapeutic Effect of Gemcitabine in a Panc02 Mouse Model of Pancreatic Ductal Adenocarcinoma
por: Takhsha, Farnaz Sedigheh, et al.
Publicado: (2021)

A cationic polymeric prodrug with chemotherapeutic self-sensibilization co-delivering MMP-9 shRNA plasmid for a combined therapy to nasopharyngeal carcinoma
por: Liu, Tao, et al.
Publicado: (2019)

Tuberculosis: The Chemotherapeutic Approaches
por: Brownlee, George
Publicado: (1949)

Evaluation of Chemotherapeutic Agents
por: Engstrom, W. W.
Publicado: (1949)

Chemotherapeutics for vivax malaria
por: Baird, J Kevin
Publicado: (2012)

Invasive ductal carcinoma within fibroadenoma and lung metastases
por: Abu-Rahmeh, Zuhair, et al.
Publicado: (2012)

Structural and Functional Characterization of New SsoPox Variant Points to the Dimer Interface as a Driver for the Increase in Promiscuous Paraoxonase Activity
por: Suzumoto, Yoko, et al.
Publicado: (2020)

Acute Splenic Infarction at an Academic General Hospital Over 10 Years: Presentation, Etiology, and Outcome
por: Ami, Schattner, et al.
Publicado: (2015)

Inhibition of MMP1, MMP2 and MMP8 by mepacrine
por: Pollaschek, C, et al.
Publicado: (2003)

Targeting both tumour-associated CXCR2(+) neutrophils and CCR2(+) macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma
por: Nywening, Timothy M, et al.
Publicado: (2018)

Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents
por: Jo, Ukhyun, et al.
Publicado: (2021)

High Glucose Promotes Pancreatic Ductal Adenocarcinoma Gemcitabine Resistance and Invasion through Modulating ROS/MMP-3 Signaling Pathway
por: Deng, Junyuan, et al.
Publicado: (2022)

Highly active enzymes by automated combinatorial backbone assembly and sequence design
por: Lapidoth, Gideon, et al.
Publicado: (2018)

MMP-1, MMP-3 and MMP-10 are involved in the degradation of cartilage
por: Tolboom, TCA, et al.
Publicado: (2001)

Evaluation of Chemotherapeutic Compounds in the Reticuloses*
por: Paterson, Edith
Publicado: (1958)

Integrin Targeted Delivery of Chemotherapeutics
por: Chen, Kai, et al.
Publicado: (2011)

Pharmacogenomics of chemotherapeutic susceptibility and toxicity
por: Moen, Erika L, et al.
Publicado: (2012)

Chemotherapeutic Interventions Against Tuberculosis
por: Shakya, Neeraj, et al.
Publicado: (2012)

Wilms’ tumour and chemotherapeutic access
por: Yasri, Sora, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4e61pjqpkn8kp7cdpi5mbr57le